MAGE-6 (168-176)

MAGE-6 (168-176) is a synthetic peptide corresponding to amino acid residues 168 through 176 of the melanoma-associated antigen 6 (MAGE-6) protein. As a member of the MAGE family, this peptide segment plays a significant role in immunological and oncological research, particularly due to its relevance as a tumor-associated epitope. The defined sequence offers a valuable tool for scientists investigating antigen processing, immune recognition, and peptide-protein interactions involving cancer-testis antigens. Its biochemical properties make it a key component in studies focused on understanding the molecular basis of immune responses against tumor cells, as well as broader applications in peptide-based assay development and epitope mapping.

Epitope mapping: MAGE-6 (168-176) serves as a critical reagent in the identification and characterization of T cell epitopes within the MAGE-6 protein. Researchers utilize this peptide to delineate the specific regions recognized by cytotoxic T lymphocytes, enabling detailed analysis of antigenic determinants that elicit immune responses against melanoma and other malignancies expressing MAGE antigens. Such studies contribute to the broader understanding of tumor immunogenicity and support the discovery of novel immunotherapeutic targets.

Immunological assay development: The defined sequence of this peptide allows it to be employed as a standard or control in various immunological assays, such as enzyme-linked immunospot (ELISPOT) assays, peptide-MHC tetramer staining, and in vitro T cell activation experiments. By incorporating the peptide into these platforms, researchers can quantify antigen-specific immune responses, validate assay specificity, and optimize detection protocols for MAGE-6-restricted T cell populations. These applications are fundamental for advancing translational immunology and vaccine research.

Peptide-protein interaction studies: The MAGE-6 (168-176) peptide is frequently used to investigate the molecular interactions between short antigenic peptides and major histocompatibility complex (MHC) molecules. Structural and biophysical studies involving this peptide help elucidate the binding affinity, stability, and conformational dynamics of peptide-MHC complexes, informing the rational design of peptide-based immunogens and advancing knowledge of antigen processing pathways.

Peptide synthesis and quality control: As a representative fragment of the MAGE-6 protein, this peptide is valuable in the optimization and validation of solid-phase peptide synthesis protocols. Synthetic chemists and quality control laboratories utilize it to assess coupling efficiency, purity assessment methods, and analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry. These processes ensure the reproducibility and reliability of peptide production workflows in both research and industrial settings.

Antigen presentation research: MAGE-6 (168-176) is instrumental in dissecting the mechanisms underlying antigen processing and presentation by professional antigen-presenting cells. By tracking the uptake, processing, and display of the peptide on MHC class I molecules, scientists gain insights into the efficiency and specificity of antigen presentation pathways relevant to tumor immunology. Such investigations support the development of strategies to enhance immune recognition of cancer-associated antigens and inform the design of next-generation immunotherapeutic approaches.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum